CDK4/6 inhibitor-mediatated radiosensitization of estrogen receptor positive breast cancer

被引：0
|
作者：
Pesch, Andrea M. [1 ]
Hirsh, Nicole [1 ]
Chandler, Benjamin C. [1 ]
Michmerhuizen, Anna R. [1 ]
Ritter, Cassandra L. [1 ]
Androsiglio, Marlie [1 ]
Wilder-Romans, Kari [1 ]
Liu, Meilan [1 ]
Gersch, Christina L. [1 ]
Larios, Jose M. [1 ]
Rae, James M. [1 ]
Speers, Corey W. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-6280
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6280
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective
    Zhou, Fiona H.
    Downton, Teesha
    Freelander, Allegra
    Hurwitz, Joshua
    Caldon, C. Elizabeth
    Lim, Elgene
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [2] Radiosensitization of Estrogen Receptor Positive Breast Cancers with Short-Term CDK4/6 Inhibition
    Pesch, A.
    Hirsh, N.
    Chandler, B.
    Michmerhuizen, A. R.
    Wilder-Romans, K.
    Liu, M.
    Ritter, C.
    Androsiglio, M.
    Gersch, C.
    Larios, J.
    Pierce, L. J.
    Rae, J.
    Speers, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S57 - S58
  • [3] Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
    Scheidemann, Erin R.
    Shajahan-Haq, Ayesha N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [4] RB loss mitigates CDK4/6 inhibitor-mediated radiosensitization of estrogen receptor positive (ER plus ) breast cancers.
    Pesch, Andrea M.
    Hirsh, Nicole
    Michmerhuizen, Anna R.
    Chandler, Benjamin C.
    Wilder-Romans, Kari
    Liu, Meilan
    Cobain, Erin
    Pierce, Lori J.
    Rae, James M.
    Speers, Corey
    CLINICAL CANCER RESEARCH, 2021, 27 (08)
  • [5] Overcoming resistance to inhibitors of CDK4/6 and BET in estrogen receptor-positive breast cancer
    Cosin, Marc
    Tian, Tian
    Oliveros, Winona
    Kharenko, Olesya A.
    van der Horst, Edward H.
    Patel, Reena G.
    Calosing, Cyrus
    Campeau, Eric
    Jahagirdar, Ravi
    Lakhotia, Sanjay
    Mele, Marta
    Palafox, Marta
    Arribas, Joaquin
    Oliveira, Mafalda
    Saura, Cristina
    Serra, Violeta
    Peiro, Sandra
    CANCER RESEARCH, 2020, 80 (16)
  • [6] The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer
    Talia, Marianna
    Cirillo, Francesca
    Scordamaglia, Domenica
    Di Dio, Marika
    Zicarelli, Azzurra
    De Rosis, Salvatore
    Miglietta, Anna Maria
    Capalbo, Carlo
    De Francesco, Ernestina Marianna
    Belfiore, Antonino
    Grande, Fedora
    Rizzuti, Bruno
    Occhiuzzi, Maria Antonietta
    Fortino, Giancarlo
    Guzzo, Antonella
    Greco, Gianluigi
    Maggiolini, Marcello
    Lappano, Rosamaria
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [7] Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
    Herrera-Abreu, Maria Teresa
    Palafox, Marta
    Asghar, Uzma
    Rivas, Martin A.
    Cutts, Rosalind J.
    Garcia-Murillas, Isaac
    Pearson, Alex
    Guzman, Marta
    Rodriguez, Olga
    Grueso, Judit
    Bellet, Meritxell
    Cortes, Javier
    Elliott, Richard
    Pancholi, Sunil
    Baselga, Jose
    Dowsett, Mitch
    Martin, Lesley-Ann
    Turner, Nicholas C.
    Serra, Violeta
    CANCER RESEARCH, 2016, 76 (08) : 2301 - 2313
  • [8] Synergistic targeting of CDK4/6 and BCL-2 pathways in estrogen receptor positive breast cancer
    Whittle, J. R.
    Vaillant, F.
    Policheni, A. N.
    Liu, K.
    Pal, B.
    Giner, G.
    Fernandez, K.
    Gray, D. H.
    Caldon, C. E.
    Smyth, G. K.
    Visvader, J. E.
    Lindeman, G. J.
    CANCER RESEARCH, 2019, 79 (04)
  • [9] Differential metabolic response of triple-negative and estrogen receptor-positive breast cancer cells to abemaciclib, a CDK4/6 inhibitor
    Jiang, Jun
    Bao, Xun
    Jiang, Yuanyuan
    Yue, Yang
    Huettemann, Maik
    Li, Jing
    CANCER RESEARCH, 2024, 84 (06)
  • [10] Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer
    Portman, Neil
    Alexandrou, Sarah
    Carson, Emma
    Wang, Shudong
    Lim, Elgene
    Caldon, C. Elizabeth
    ENDOCRINE-RELATED CANCER, 2019, 26 (01) : R15 - R30
12345